|
Volumn 23, Issue 4, 2014, Pages 575-580
|
Efficacy of probiotic therapy in full-term infants with critical illness
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN A;
PLACEBO;
PROBIOTIC AGENT;
BLOOD;
CHINA;
CONTROLLED STUDY;
CRITICAL ILLNESS;
CROSS INFECTION;
DOUBLE BLIND PROCEDURE;
ENTEROCOLITIS, NECROTIZING;
HUMAN;
INFANT, NEWBORN, DISEASES;
MULTIPLE ORGAN FAILURE;
NEWBORN;
NEWBORN INTENSIVE CARE;
PNEUMONIA;
RANDOMIZED CONTROLLED TRIAL;
SEPSIS;
CHINA;
CRITICAL ILLNESS;
CROSS INFECTION;
DOUBLE-BLIND METHOD;
ENTEROCOLITIS, NECROTIZING;
HUMANS;
IMMUNOGLOBULIN A;
INFANT, NEWBORN;
INFANT, NEWBORN, DISEASES;
INTENSIVE CARE, NEONATAL;
MULTIPLE ORGAN FAILURE;
PLACEBOS;
PNEUMONIA;
PROBIOTICS;
SEPSIS;
|
EID: 84925547089
PISSN: 09647058
EISSN: None
Source Type: Journal
DOI: 10.6133/apjcn.2014.23.4.14 Document Type: Article |
Times cited : (24)
|
References (0)
|